Foldrx Pharmaceuticals' Acquisition

Foldrx Pharmaceuticals was acquired by Pfizer on September 14, 2010.

FoldRx is a leader in the discovery and development of disease-modifying drug therapies for diseases of protein misfolding and amyloidosis.…

Articles about Foldrx Pharmaceuticals' Acquisition: